Details for Luxembourg Supplementary Protection Certificate: LUC00012
Luxembourg Supplementary Protection Certificate: LUC00012
| Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2100614 | LUC00012 | Luxembourg | PRODUCT NAME: OLARATUMAB ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (LARTRUVO); AUTHORISATION NUMBER AND DATE: EU/1/16/1143 20161111 | ⤷ Start Trial |
| >Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |
